Quantum Descriptors for Predicting and Understanding the Structure-Activity Relationships of Michael Acceptor Warheads

07 July 2023, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Predictive modeling and understanding chemical warhead reactivities have the potential to accelerate targeted covalent drug discovery. Recently, the carbanion formation free energies as well as other ground-state electronic properties from the den- sity functional theory (DFT) calculations have been proposed as predictors of glutathione reactivities of Michael acceptors; however, no clear consensus exists. By profiling the thiol-Michael reactions of a diverse set of singly- and doubly-activated olefins including several model warheads related to afatinib, here we reexamined the question of whether low-cost electronic properties can be used as predictors of reaction barriers. The electronic properties related to the carbanion intermediate were found to be strong predictors, e.g., the change in the Cβ charge accompanying carbanion formation. The least expensive reactant-only properties, the electrophilicity index and the Cβ charge also show strong rank correlations, suggesting their utility as quantum descriptors. A second objective of the work is to clarify the effect of the β-dimethylaminomethyl (DMAM) substitution which is incorporated in the warheads of several FDA-approved covalent drugs. Our data suggests that the beta-DMAM substitution is cationic at neutral pH in solution and it promotes acrylamide’s intrinsic reactivity by enhancing the charge accumulation at Calpha upon carbanion formation. In contrast, the inductive effect of the beta-trimethylaminomethyl substitution is diminished due to steric hindrance. Together, these results reconcile the current views of the intrinsic reactivities of acrylamides and contribute to large-scale predictive modeling and understanding of the structure-activity relationships of Michael acceptors for rational TCI design.

Keywords

covalent drug design
quantum calculations
structure-activity relationships

Supplementary materials

Title
Description
Actions
Title
Supporting Information
Description
Supplemental tables and figures
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.